BNP Paribas Financial Markets’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $114K | Buy |
16,495
+604
| +4% | +$4.66K | ﹤0.01% | 4308 |
|
|
2025
Q4 | $140K | Sell |
15,891
-49,644
| -76% | -$273K | ﹤0.01% | 4210 |
|
|
2025
Q3 | $327K | Buy |
65,535
+56,556
| +630% | +$262K | ﹤0.01% | 3778 |
|
|
2025
Q2 | $42.4K | Sell |
8,979
-23,201
| -72% | -$101K | ﹤0.01% | 4319 |
|
|
2025
Q1 | $148K | Sell |
32,180
-40,132
| -55% | -$187K | ﹤0.01% | 3876 |
|
|
2024
Q4 | $346K | Buy |
72,312
+10,074
| +16% | +$48.4K | ﹤0.01% | 3532 |
|
|
2024
Q3 | $292K | Buy |
62,238
+57,393
| +1,185% | +$308K | ﹤0.01% | 3088 |
|
|
2024
Q2 | $27.4K | Sell |
4,845
-96,518
| -95% | -$498K | ﹤0.01% | 3593 |
|
|
2024
Q1 | $417K | Buy |
101,363
+41,767
| +70% | +$167K | ﹤0.01% | 2946 |
|
|
2023
Q4 | $251K | Buy |
59,596
+20,206
| +51% | +$81.5K | ﹤0.01% | 3117 |
|
|
2023
Q3 | $170K | Sell |
39,390
-38,532
| -49% | -$214K | ﹤0.01% | 3153 |
|
|
2023
Q2 | $514K | Sell |
77,922
-84,080
| -52% | -$539K | ﹤0.01% | 2568 |
|
|
2023
Q1 | $1.1M | Buy |
162,002
+90,573
| +127% | +$637K | ﹤0.01% | 2248 |
|
|
2022
Q4 | $528K | Sell |
71,429
-12,529
| -15% | -$122K | ﹤0.01% | 2541 |
|
|
2022
Q3 | $830K | Buy |
83,958
+63,512
| +311% | +$671K | ﹤0.01% | 2628 |
|
|
2022
Q2 | $223K | Sell |
20,446
-3,862
| -16% | -$40K | ﹤0.01% | 3035 |
|
|
2022
Q1 | $275K | Sell |
24,308
-11,701
| -32% | -$154K | ﹤0.01% | 3013 |
|
|
2021
Q4 | $565K | Sell |
36,009
-29,704
| -45% | -$518K | ﹤0.01% | 2946 |
|
|
2021
Q3 | $1.13M | Buy |
65,713
+36,663
| +126% | +$642K | ﹤0.01% | 2289 |
|
|
2021
Q2 | $625K | Sell |
29,050
-1,057
| -4% | -$18.9K | ﹤0.01% | 2422 |
|
|
2021
Q1 | $452K | Buy |
30,107
+886
| +3% | +$14.3K | ﹤0.01% | 2621 |
|
|
2020
Q4 | $384K | Buy |
29,221
+15,490
| +113% | +$186K | ﹤0.01% | 2586 |
|
|
2020
Q3 | $133K | Sell |
13,731
-45,192
| -77% | -$483K | ﹤0.01% | 2966 |
|
|
2020
Q2 | $674K | Buy |
58,923
+28,625
| +94% | +$324K | ﹤0.01% | 1974 |
|
|
2020
Q1 | $314K | Buy |
30,298
+18,471
| +156% | +$229K | ﹤0.01% | 2616 |
|
|
2019
Q4 | $194K | Buy |
11,827
+3,635
| +44% | +$55K | ﹤0.01% | 2965 |
|
|
2019
Q3 | $109K | Buy |
8,192
+2,458
| +43% | +$34.3K | ﹤0.01% | 3083 |
|
|
2019
Q2 | $80.8K | Sell |
5,734
-4,952
| -46% | -$78.8K | ﹤0.01% | 3155 |
|
|
2019
Q1 | $197K | Buy |
10,686
+10,669
| +62,759% | +$243K | ﹤0.01% | 2716 |
|
|
2018
Q4 | $444 | Sell |
17
-1,686
| -99% | -$39.6K | ﹤0.01% | 4013 |
|
|
2018
Q3 | $39.1K | Hold |
1,703
| – | – | ﹤0.01% | 3150 |
|
|
2018
Q2 | $32.4K | Sell |
1,703
-7,639
| -82% | -$128K | ﹤0.01% | 3299 |
|
|
2018
Q1 | $157K | Buy |
9,342
+73
| +0.8% | +$1.22K | ﹤0.01% | 2935 |
|
|
2017
Q4 | $141K | Buy |
9,269
+4,765
| +106% | +$70.7K | ﹤0.01% | 3132 |
|
|
2017
Q3 | $80.6K | Sell |
4,504
-284
| -6% | -$4.75K | ﹤0.01% | 2902 |
|
|
2017
Q2 | $78K | Buy |
4,788
+4,581
| +2,213% | +$66K | ﹤0.01% | 2942 |
|
|
2017
Q1 | $2.9K | Sell |
207
-1,846
| -90% | -$26.3K | ﹤0.01% | 3438 |
|
|
2016
Q4 | $32.7K | Sell |
2,053
-483
| -19% | -$7.76K | ﹤0.01% | 3005 |
|
|
2016
Q3 | $42.2K | Sell |
2,536
-40,975
| -94% | -$552K | ﹤0.01% | 2505 |
|
|
2016
Q2 | $487K | Buy |
43,511
+1,411
| +3% | +$13.7K | ﹤0.01% | 1523 |
|
|
2016
Q1 | $352K | Sell |
42,100
-51,612
| -55% | -$424K | ﹤0.01% | 1306 |
|
|
2015
Q4 | $872K | Buy |
93,712
+84,659
| +935% | +$845K | ﹤0.01% | 1155 |
|
|
2015
Q3 | $102K | Buy |
9,053
+5,576
| +160% | +$68.2K | ﹤0.01% | 2379 |
|
|
2015
Q2 | $44.1K | Buy |
3,477
+2,548
| +274% | +$27.5K | ﹤0.01% | 2570 |
|
|
2015
Q1 | $8.64K | Buy |
+929
| New | +$10.5K | ﹤0.01% | 2833 |
|
|
2014
Q4 | – | Sell |
-2,032
| Closed | -$21.1K | – | 3176 |
|
|
2014
Q3 | $21.1K | Buy |
+2,032
| New | +$26.6K | ﹤0.01% | 3131 |
|
|
2014
Q1 | – | Sell |
-430
| Closed | -$5.34K | – | 3819 |
|
|
2013
Q4 | $5.34K | Buy |
+430
| New | +$4.32K | ﹤0.01% | 3056 |
|
|
2013
Q3 | – | Sell |
-12,078
| Closed | -$97.6K | – | 2722 |
|
|
2013
Q2 | $97.6K | Buy |
+12,078
| New | +$81.3K | ﹤0.01% | 2536 |
|
Other funds holding VNDA
ACM
VCM
BNP Paribas Financial Markets's VNDA Position: Q1 2026 in Review
BNP Paribas Financial Markets increased its Vanda Pharmaceuticals (VNDA) stake by 3.8% in Q1 2026, buying an estimated $4.66K and bringing the position to 16,495 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #4308.
BNP Paribas Financial Markets first reported a position in VNDA in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.13M in Q3 2021. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.
- BNP Paribas Financial Markets held 16,495 shares of Vanda Pharmaceuticals worth $114K as of Q1 2026.
- BNP Paribas Financial Markets bought 604 Vanda Pharmaceuticals shares in Q1 2026, an estimated $4.66K.
- Vanda Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4308 holding.
- BNP Paribas Financial Markets first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
- BNP Paribas Financial Markets's Vanda Pharmaceuticals position peaked at $1.13M in Q3 2021.
- 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.